PROGESTERONE

PROGESTERONE was reported 23696 times

PROGESTERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TEMPERATURE REGULATION DISORDER 494 0.2215
1 OVARIAN HYPERSTIMULATION SYNDROME 361 0.1547
2 AUTOIMMUNE DERMATITIS 21 0.1391
3 PROGESTERONE DECREASED 36 0.1158
4 FOOD ALLERGY 627 0.0812
5 PLACENTA ACCRETA 17 0.0783
6 FALLOPIAN TUBE DISORDER 23 0.0780
7 BLOOD OESTROGEN DECREASED 54 0.0768
8 ADNEXAL TORSION 21 0.0662
9 FOETAL DEATH 331 0.0638
10 ENDOMETRIAL THICKENING 34 0.0610
11 PREMATURE AGEING 17 0.0578
12 OVARIAN ENLARGEMENT 20 0.0521
13 POSTMENOPAUSAL HAEMORRHAGE 126 0.0483
14 CONGENITAL UMBILICAL HERNIA 17 0.0456
15 COELIAC DISEASE 447 0.0455
16 KERATOCONUS 17 0.0452
17 IMMUNODEFICIENCY 615 0.0412
18 BURSITIS 454 0.0374
19 ENDOMETRIAL HYPERPLASIA 30 0.0370
20 BUTTERFLY RASH 37 0.0365
21 NEONATAL TACHYPNOEA 15 0.0363
22 ABORTION THREATENED 18 0.0361
23 PLAGIOCEPHALY 18 0.0361
24 NEONATAL ASPHYXIA 25 0.0353
25 EOSINOPHILIC PNEUMONIA ACUTE 29 0.0335
26 CYANOSIS NEONATAL 21 0.0328
27 HYPOSPADIAS 65 0.0312
28 BLOOD OESTROGEN INCREASED 18 0.0306
29 DEVELOPMENTAL HIP DYSPLASIA 24 0.0288
30 HELLP SYNDROME 17 0.0277
31 PREMATURE LABOUR 156 0.0276
32 PROGESTERONE RECEPTOR ASSAY POSITIVE 25 0.0268
33 CONGENITAL HYDRONEPHROSIS 19 0.0266
34 UTERINE POLYP 47 0.0262
35 RESPIRATORY DISORDER NEONATAL 42 0.0259
36 MENOPAUSAL SYMPTOMS 60 0.0258
37 PRESCRIBED OVERDOSE 464 0.0240
38 TWIN PREGNANCY 20 0.0238
39 HYPOPLASTIC LEFT HEART SYNDROME 16 0.0236
40 PRETERM PREMATURE RUPTURE OF MEMBRANES 28 0.0233
41 HUMAN HERPESVIRUS 6 INFECTION 44 0.0233
42 CONGENITAL ANOMALY 175 0.0226
43 OESTROGEN RECEPTOR ASSAY POSITIVE 25 0.0220
44 PULMONARY ARTERY STENOSIS CONGENITAL 16 0.0219
45 ECTOPIC PREGNANCY 65 0.0211
46 AMNIOTIC CAVITY INFECTION 15 0.0207
47 HAEMORRHAGE IN PREGNANCY 29 0.0202
48 MENOPAUSE 52 0.0202
49 PREMATURE RUPTURE OF MEMBRANES 47 0.0195
50 GESTATIONAL DIABETES 92 0.0193
51 ATRIAL SEPTAL DEFECT 151 0.0180
52 DEATH NEONATAL 25 0.0180
53 MICROCEPHALY 23 0.0179
54 HORMONE LEVEL ABNORMAL 85 0.0174
55 FOETAL HEART RATE ABNORMAL 16 0.0173
56 OLIGOHYDRAMNIOS 57 0.0171
57 NEONATAL RESPIRATORY DISTRESS 16 0.0170
58 CRYPTORCHISM 19 0.0169
59 VENTRICULAR SEPTAL DEFECT 91 0.0159
60 EXPOSURE DURING PREGNANCY 981 0.0158
61 BREAST TENDERNESS 117 0.0155
62 PRODUCT ODOUR ABNORMAL 160 0.0153
63 HEPATIC NECROSIS 57 0.0151
64 SUBCLAVIAN VEIN THROMBOSIS 17 0.0149
65 DRUG EXPOSURE BEFORE PREGNANCY 15 0.0148
66 HAEMANGIOMA 34 0.0147
67 SMALL FOR DATES BABY 71 0.0143
68 HYPOTONIA NEONATAL 22 0.0141
69 LOW BIRTH WEIGHT BABY 111 0.0140
70 INTERMENSTRUAL BLEEDING 78 0.0139
71 UPPER RESPIRATORY TRACT INFECTION 643 0.0139
72 CONTRAINDICATED PRODUCT ADMINISTERED 419 0.0138
73 PRODUCT ADHESION ISSUE 477 0.0133
74 PRE-ECLAMPSIA 62 0.0130
75 FOETAL GROWTH RESTRICTION 79 0.0130
76 RASH ERYTHEMATOUS 610 0.0127
77 PATENT DUCTUS ARTERIOSUS 50 0.0126
78 INTRA-UTERINE DEATH 20 0.0125
79 PREMATURE DELIVERY 196 0.0123
80 UTERINE HAEMORRHAGE 52 0.0122
81 PREMATURE BABY 365 0.0121
82 BREECH PRESENTATION 15 0.0119
83 MATERNAL EXPOSURE BEFORE PREGNANCY 81 0.0118
84 ABORTION MISSED 15 0.0118
85 ADNEXA UTERI PAIN 15 0.0117
86 GESTATIONAL HYPERTENSION 15 0.0116
87 NEONATAL RESPIRATORY DISTRESS SYNDROME 41 0.0116
88 PRE-EXISTING CONDITION IMPROVED 72 0.0115
89 FOETAL EXPOSURE DURING PREGNANCY 934 0.0115
90 SUSPECTED PRODUCT QUALITY ISSUE 21 0.0115
91 FLUID RETENTION 570 0.0112
92 ABORTION SPONTANEOUS 445 0.0111
93 MAST CELL ACTIVATION SYNDROME 15 0.0107
94 INFERTILITY 16 0.0106
95 PREMATURE SEPARATION OF PLACENTA 16 0.0104
96 FOETAL DISTRESS SYNDROME 22 0.0104
97 UTERINE DISORDER 24 0.0103
98 APPLICATION SITE URTICARIA 23 0.0102
99 HEPATIC ENZYME INCREASED 696 0.0102
100 ALLERGIC REACTION TO EXCIPIENT 20 0.0100
101 VAGINAL HAEMORRHAGE 430 0.0099
102 POOR QUALITY PRODUCT ADMINISTERED 104 0.0099
103 VULVOVAGINAL DISCOMFORT 43 0.0097
104 TALIPES 30 0.0096
105 TERMINAL INSOMNIA 17 0.0096
106 ABORTION 28 0.0096
107 VAGINAL DISCHARGE 97 0.0096
108 MATERNAL EXPOSURE DURING PREGNANCY 837 0.0094
109 APPLICATION SITE PRURITUS 211 0.0093
110 APPLICATION SITE RASH 127 0.0092
111 ENDOMETRIAL CANCER 20 0.0091
112 VULVOVAGINAL DRYNESS 29 0.0090
113 ADRENAL DISORDER 17 0.0088
114 BREAST ENLARGEMENT 29 0.0088
115 REACTION TO EXCIPIENT 20 0.0087
116 ABNORMAL UTERINE BLEEDING 22 0.0086
117 BREAST SWELLING 23 0.0085
118 MATERNAL EXPOSURE TIMING UNSPECIFIED 32 0.0085
119 BREAST CYST 15 0.0085
120 NORMAL NEWBORN 46 0.0085
121 BREAST CANCER FEMALE 225 0.0084
122 DECREASED IMMUNE RESPONSIVENESS 82 0.0083
123 JOINT NOISE 16 0.0081
124 BLOOD PRESSURE SYSTOLIC ABNORMAL 20 0.0081
125 PERIORBITAL OEDEMA 42 0.0081
126 LIVE BIRTH 67 0.0080
127 UTERINE LEIOMYOMA 58 0.0079
128 APPLICATION SITE IRRITATION 98 0.0079
129 NIPPLE PAIN 16 0.0079
130 SUICIDAL BEHAVIOUR 32 0.0077
131 INFUSION RELATED REACTION 501 0.0076
132 BLOOD PRESSURE DIASTOLIC INCREASED 34 0.0074
133 FINE MOTOR SKILL DYSFUNCTION 21 0.0072
134 APPLICATION SITE ERYTHEMA 190 0.0072
135 BREAST PAIN 77 0.0072
136 CHRONIC SINUSITIS 27 0.0072
137 PRODUCT ADMINISTRATION INTERRUPTED 56 0.0071
138 OVARIAN CYST 71 0.0071
139 HEAVY MENSTRUAL BLEEDING 63 0.0070
140 EOSINOPHILIC PNEUMONIA 22 0.0070
141 SPEECH DISORDER DEVELOPMENTAL 20 0.0070
142 INFUSION SITE BRUISING 15 0.0069
143 HORDEOLUM 30 0.0069
144 ENDOMETRIOSIS 33 0.0069
145 CAESAREAN SECTION 80 0.0069
146 PREGNANCY 135 0.0067
147 HOT FLUSH 507 0.0067
148 HYPERHIDROSIS 866 0.0067
149 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
150 APPLICATION SITE SWELLING 33 0.0066
151 BREAST CANCER METASTATIC 71 0.0066
152 ASTHMA 741 0.0065
153 METRORRHAGIA 111 0.0065
154 ATTENTION DEFICIT HYPERACTIVITY DISORDER 27 0.0064
155 APPLICATION SITE DISCOLOURATION 26 0.0064
156 INFUSION SITE SWELLING 40 0.0064
157 RHEUMATOID ARTHRITIS 721 0.0063
158 MATERNAL DRUGS AFFECTING FOETUS 48 0.0063
159 BRAIN FOG 97 0.0062
160 HEPATIC ENCEPHALOPATHY 57 0.0061
161 INFUSION SITE HAEMORRHAGE 20 0.0061
162 BRUXISM 32 0.0059
163 THERAPEUTIC REACTION TIME DECREASED 17 0.0058
164 AUTOIMMUNE THYROIDITIS 22 0.0058
165 EYELIDS PRURITUS 18 0.0058
166 ELECTRIC SHOCK SENSATION 16 0.0057
167 INFUSION SITE PRURITUS 18 0.0057
168 INTENTIONAL PRODUCT MISUSE 492 0.0056
169 NIGHT SWEATS 178 0.0055
170 INVASIVE DUCTAL BREAST CARCINOMA 15 0.0055
171 FEELING DRUNK 40 0.0054
172 PRODUCT SUBSTITUTION ISSUE 305 0.0053
173 JOINT SWELLING 625 0.0052
174 RHINITIS ALLERGIC 23 0.0052
175 APPLICATION SITE BURN 25 0.0051
176 PLANTAR FASCIITIS 17 0.0051
177 BLOOD THYROID STIMULATING HORMONE DECREASED 23 0.0051
178 BREAST MASS 34 0.0051
179 SNORING 19 0.0050
180 BREAST CANCER 466 0.0050
181 HYSTERECTOMY 43 0.0050
182 RETCHING 105 0.0049
183 HYPERSENSITIVITY 905 0.0049
184 MULTIPLE-DRUG RESISTANCE 15 0.0048
185 SKIN ODOUR ABNORMAL 19 0.0048
186 LYME DISEASE 16 0.0048
187 CONGESTIVE CARDIOMYOPATHY 20 0.0048
188 UMBILICAL HERNIA 22 0.0047
189 INTERVERTEBRAL DISC DEGENERATION 43 0.0046
190 HEAD DISCOMFORT 82 0.0046
191 HAIR GROWTH ABNORMAL 32 0.0046
192 DEPRESSION SUICIDAL 16 0.0046
193 POLYMENORRHOEA 16 0.0046
194 HYPERACUSIS 17 0.0046
195 ONYCHOMYCOSIS 20 0.0046
196 NERVE COMPRESSION 42 0.0045
197 DEPRESSIVE SYMPTOM 16 0.0045
198 SEASONAL ALLERGY 63 0.0044
199 IRON DEFICIENCY 20 0.0044
200 DRUG INTOLERANCE 429 0.0044
201 MATERNAL EXPOSURE DURING BREAST FEEDING 18 0.0044
202 APPLICATION SITE DRYNESS 15 0.0044
203 FIBROMYALGIA 107 0.0044
204 GLUCOSE TOLERANCE IMPAIRED 26 0.0044
205 MENISCUS INJURY 27 0.0044
206 DYSMENORRHOEA 58 0.0044
207 DRUG TOLERANCE 22 0.0043
208 VULVOVAGINAL PRURITUS 22 0.0043
209 VULVOVAGINAL MYCOTIC INFECTION 17 0.0043
210 PRODUCT USE ISSUE 810 0.0043
211 RECALLED PRODUCT ADMINISTERED 41 0.0043
212 SLEEP APNOEA SYNDROME 82 0.0043
213 POOR QUALITY SLEEP 92 0.0043
214 ERYTHEMA NODOSUM 15 0.0043
215 HANGOVER 15 0.0043
216 DRUG EXPOSURE DURING PREGNANCY 145 0.0043
217 VAGINAL INFECTION 20 0.0042
218 PHOTOSENSITIVITY REACTION 70 0.0042
219 MIDDLE INSOMNIA 79 0.0042
220 POST-TRAUMATIC STRESS DISORDER 28 0.0042
221 APPLICATION SITE EXFOLIATION 17 0.0041
222 MIGRAINE 390 0.0041
223 NEUROLOGICAL SYMPTOM 23 0.0040
224 MENSTRUAL DISORDER 33 0.0040
225 SUSPECTED OFF LABEL USE 18 0.0040
226 STREPTOCOCCAL INFECTION 22 0.0039
227 PRODUCT FORMULATION ISSUE 26 0.0039
228 INFUSION SITE ERYTHEMA 33 0.0039
229 TREATMENT FAILURE 324 0.0039
230 VITAMIN D DEFICIENCY 38 0.0039
231 STRESS FRACTURE 21 0.0039
232 SYMPTOM RECURRENCE 23 0.0038
233 ABORTION INDUCED 36 0.0038
234 THINKING ABNORMAL 71 0.0038
235 THROMBOCYTOPENIA 425 0.0038
236 DEVICE ADHESION ISSUE 58 0.0038
237 DERMATITIS CONTACT 43 0.0038
238 VULVOVAGINAL BURNING SENSATION 23 0.0038
239 ORAL HERPES 73 0.0037
240 STILLBIRTH 18 0.0037
241 DYSPAREUNIA 17 0.0037
242 NEURALGIA 90 0.0037
243 TENDON PAIN 28 0.0037
244 PSYCHIATRIC SYMPTOM 27 0.0037
245 TRICUSPID VALVE INCOMPETENCE 29 0.0036
246 MELANOCYTIC NAEVUS 16 0.0036
247 INFUSION SITE PAIN 47 0.0036
248 MALABSORPTION 19 0.0036
249 HEPATOTOXICITY 81 0.0036
250 HEREDITARY ANGIOEDEMA 39 0.0036
251 HYPOTHYROIDISM 116 0.0036
252 MADAROSIS 42 0.0036
253 MENINGIOMA 56 0.0036
254 MULTIPLE ALLERGIES 28 0.0036
255 CONSTIPATION 774 0.0035
256 TINNITUS 163 0.0035
257 INSURANCE ISSUE 54 0.0035
258 SPINAL OSTEOARTHRITIS 31 0.0035
259 BACK PAIN 812 0.0035
260 HEADACHE 2183 0.0035
261 PSORIASIS 453 0.0035
262 SYNOVIAL CYST 16 0.0035
263 ROSACEA 16 0.0034
264 HYPERTENSION 723 0.0034
265 SINUSITIS 346 0.0034
266 ABDOMINAL PAIN LOWER 85 0.0034
267 TENDONITIS 52 0.0034
268 RESTLESS LEGS SYNDROME 61 0.0034
269 ONYCHOCLASIS 23 0.0033
270 FOOT DEFORMITY 37 0.0033
271 VULVOVAGINAL PAIN 16 0.0033
272 CYST 41 0.0033
273 PELVIC PAIN 60 0.0033
274 HEPATIC CIRRHOSIS 62 0.0033
275 PANIC ATTACK 120 0.0033
276 DRUG-INDUCED LIVER INJURY 103 0.0033
277 ABDOMINAL DISTENSION 342 0.0033
278 CARDIAC FLUTTER 21 0.0032
279 HYPERTHYROIDISM 47 0.0032
280 MUCOUS STOOLS 16 0.0032
281 FOOT FRACTURE 61 0.0032
282 ERYTHEMA 661 0.0032
283 EYE PAIN 181 0.0032
284 SOMNAMBULISM 21 0.0032
285 CRYING 116 0.0032
286 PARAESTHESIA ORAL 46 0.0032
287 EYE INFECTION 36 0.0032
288 APPLICATION SITE PAIN 70 0.0032
289 MOOD SWINGS 101 0.0032
290 OSTEOPENIA 48 0.0032
291 FORMICATION 22 0.0032
292 GASTROENTERITIS VIRAL 57 0.0032
293 IMPAIRED GASTRIC EMPTYING 43 0.0032
294 DISEASE RECURRENCE 149 0.0031
295 PRODUCT PHYSICAL ISSUE 63 0.0031
296 PRODUCT COLOUR ISSUE 16 0.0031
297 MYASTHENIA GRAVIS 25 0.0031
298 SKIN WARM 18 0.0031
299 ASTHENOPIA 17 0.0031
300 INSOMNIA 811 0.0030
301 DRUG EFFECT LESS THAN EXPECTED 45 0.0030
302 LIGAMENT SPRAIN 30 0.0030
303 INTERVERTEBRAL DISC PROTRUSION 66 0.0030
304 DRY EYE 150 0.0030
305 HYPERCHOLESTEROLAEMIA 29 0.0030
306 FEELING JITTERY 57 0.0030
307 THERAPEUTIC RESPONSE UNEXPECTED 134 0.0030
308 APPLICATION SITE REACTION 21 0.0030
309 PRODUCT SIZE ISSUE 16 0.0030
310 TOOTH INFECTION 39 0.0030
311 EXOSTOSIS 27 0.0030
312 BODY TEMPERATURE DECREASED 29 0.0029
313 OCULAR DISCOMFORT 33 0.0029
314 OVARIAN CANCER 27 0.0029
315 MITRAL VALVE INCOMPETENCE 33 0.0029
316 BRADYPHRENIA 19 0.0029
317 ASCITES 85 0.0029
318 MUSCLE STRAIN 25 0.0029
319 MICTURITION URGENCY 33 0.0029
320 BLOOD IRON DECREASED 34 0.0029
321 VITREOUS FLOATERS 28 0.0028
322 PHOTOPSIA 18 0.0028
323 LIMB DISCOMFORT 88 0.0028
324 INITIAL INSOMNIA 29 0.0028
325 FOREIGN BODY SENSATION IN EYES 18 0.0028
326 HEART RATE INCREASED 279 0.0028
327 SCAR 48 0.0028
328 POOR VENOUS ACCESS 29 0.0028
329 HUNGER 39 0.0028
330 DEPRESSED MOOD 148 0.0028
331 UPPER-AIRWAY COUGH SYNDROME 23 0.0028
332 NERVE INJURY 31 0.0028
333 ANAL INCONTINENCE 25 0.0028
334 PANIC REACTION 20 0.0028
335 ERYTHEMA OF EYELID 15 0.0028
336 SKIN SWELLING 24 0.0028
337 PHARYNGEAL SWELLING 27 0.0028
338 POLYP 18 0.0027
339 PALPITATIONS 320 0.0027
340 INFUSION SITE EXTRAVASATION 17 0.0027
341 THYROID DISORDER 42 0.0027
342 MOOD ALTERED 74 0.0027
343 NASAL DRYNESS 17 0.0027
344 ANXIETY 768 0.0027
345 INFECTION 389 0.0027
346 NECK PAIN 150 0.0027
347 SINUS DISORDER 53 0.0027
348 DIVERTICULITIS 74 0.0027
349 DISTURBANCE IN ATTENTION 144 0.0027
350 WRIST FRACTURE 32 0.0027
351 FUNGAL INFECTION 88 0.0026
352 TONGUE DISORDER 19 0.0026
353 RESPIRATORY TRACT INFECTION 68 0.0026
354 NODULE 34 0.0026
355 MENORRHAGIA 51 0.0026
356 EAR INFECTION 69 0.0026
357 CONCUSSION 20 0.0026
358 SCOLIOSIS 16 0.0026
359 FACIAL PAIN 23 0.0026
360 FOREIGN BODY IN REPRODUCTIVE TRACT 23 0.0026
361 ROTATOR CUFF SYNDROME 33 0.0026
362 INJECTION SITE URTICARIA 63 0.0026
363 AMENORRHOEA 45 0.0026
364 ARTHROPOD BITE 19 0.0026
365 OROPHARYNGEAL PAIN 236 0.0025
366 PERIPHERAL COLDNESS 35 0.0025
367 CANDIDA INFECTION 43 0.0025
368 ABNORMAL DREAMS 70 0.0025
369 DIVERTICULUM 18 0.0025
370 MUSCLE TIGHTNESS 41 0.0025
371 METASTASES TO LYMPH NODES 17 0.0025
372 SWELLING FACE 164 0.0025
373 OVERDOSE 542 0.0025
374 PRODUCT TASTE ABNORMAL 34 0.0025
375 GASTROOESOPHAGEAL REFLUX DISEASE 202 0.0025
376 CARPAL TUNNEL SYNDROME 35 0.0025
377 COVID-19 438 0.0025
378 FEELING HOT 152 0.0025
379 JOINT STIFFNESS 65 0.0025
380 PAIN 1522 0.0025
381 FEELING ABNORMAL 592 0.0025
382 WEIGHT INCREASED 553 0.0025
383 HYPERPROLACTINAEMIA 16 0.0025
384 APPLICATION SITE VESICLES 16 0.0025
385 AUTOIMMUNE DISORDER 24 0.0025
386 HERPES SIMPLEX 16 0.0025
387 LARGE INTESTINE POLYP 17 0.0025
388 APHTHOUS ULCER 19 0.0024
389 TOOTH FRACTURE 27 0.0024
390 VERTIGO 149 0.0024
391 DEPRESSION 555 0.0024
392 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
393 INTENTIONAL PRODUCT USE ISSUE 213 0.0024
394 EMBEDDED DEVICE 24 0.0024
395 TEMPERATURE INTOLERANCE 25 0.0024
396 PRODUCT QUALITY ISSUE 329 0.0024
397 BRONCHITIS 179 0.0024
398 BLOOD PRESSURE FLUCTUATION 58 0.0024
399 NASAL CONGESTION 142 0.0024
400 GALLBLADDER DISORDER 43 0.0024
401 FATIGUE 1870 0.0024
402 EYE IRRITATION 138 0.0024
403 KIDNEY INFECTION 47 0.0024
404 PHOTOPHOBIA 45 0.0024
405 IRON DEFICIENCY ANAEMIA 22 0.0024
406 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 21 0.0024
407 PRODUCT ADMINISTRATION ERROR 48 0.0024
408 FEELING COLD 66 0.0024
409 MUSCLE SPASMS 435 0.0024
410 OBSESSIVE-COMPULSIVE DISORDER 19 0.0024
411 IMPAIRED QUALITY OF LIFE 34 0.0024
412 RENAL PAIN 25 0.0024
413 RHINITIS 19 0.0024
414 SURGERY 138 0.0024
415 INTENTIONAL DOSE OMISSION 67 0.0023
416 RASH 1022 0.0023
417 IMPAIRED WORK ABILITY 50 0.0023
418 EMOTIONAL DISORDER 72 0.0023
419 OSTEOARTHRITIS 99 0.0023
420 IRRITABLE BOWEL SYNDROME 50 0.0023
421 DISCOMFORT 142 0.0023
422 MUSCULOSKELETAL CHEST PAIN 36 0.0023
423 THERAPY CESSATION 119 0.0023
424 BLADDER DISORDER 23 0.0023
425 EYE DISCHARGE 24 0.0023
426 SLEEP DISORDER 163 0.0023
427 HEPATIC STEATOSIS 43 0.0023
428 IMPAIRED DRIVING ABILITY 26 0.0023
429 AFFECT LABILITY 22 0.0023
430 PRODUCT USE COMPLAINT 36 0.0023
431 IRRITABILITY 137 0.0023
432 CYSTITIS 72 0.0023
433 SENSATION OF FOREIGN BODY 19 0.0023
434 BURNING SENSATION 158 0.0023
435 DEFORMITY 21 0.0022
436 EAR DISCOMFORT 23 0.0022
437 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 41 0.0022
438 QUALITY OF LIFE DECREASED 30 0.0022
439 NOCTURIA 27 0.0022
440 PRODUCT USE IN UNAPPROVED INDICATION 551 0.0022
441 HEART RATE DECREASED 78 0.0022
442 NERVOUSNESS 116 0.0022
443 VISUAL FIELD DEFECT 16 0.0022
444 MUSCLE TWITCHING 51 0.0022
445 TENDERNESS 23 0.0022
446 DERMATITIS ATOPIC 116 0.0022
447 PYELONEPHRITIS 19 0.0022
448 HYPERAESTHESIA 18 0.0022
449 GASTROINTESTINAL PAIN 24 0.0022
450 THROAT TIGHTNESS 59 0.0022
451 DRY MOUTH 176 0.0022
452 OFF LABEL USE 1899 0.0022
453 AFFECTIVE DISORDER 17 0.0022
454 HIATUS HERNIA 28 0.0022
455 PYREXIA 744 0.0021
456 VISION BLURRED 294 0.0021
457 ALOPECIA 420 0.0021
458 CHROMATURIA 48 0.0021
459 ILLNESS 219 0.0021
460 HYPERBILIRUBINAEMIA 22 0.0021
461 THERAPEUTIC PRODUCT EFFECT DECREASED 95 0.0021
462 INJECTION SITE PRURITUS 142 0.0021
463 SKIN LACERATION 23 0.0021
464 VITAMIN D DECREASED 18 0.0021
465 GASTRITIS 55 0.0021
466 SWOLLEN TONGUE 65 0.0021
467 DYSGEUSIA 154 0.0021
468 THROAT IRRITATION 93 0.0021
469 SINUS CONGESTION 28 0.0021
470 HYPERTENSIVE CRISIS 23 0.0021
471 EYELID PTOSIS 21 0.0021
472 PARAESTHESIA 325 0.0021
473 INCREASED TENDENCY TO BRUISE 19 0.0021
474 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
475 JOINT INJURY 44 0.0021
476 CHILLS 241 0.0021
477 BLOOD CALCIUM INCREASED 18 0.0021
478 ORAL CANDIDIASIS 27 0.0020
479 GROIN PAIN 18 0.0020
480 FREQUENT BOWEL MOVEMENTS 55 0.0020
481 CEREBRAL DISORDER 15 0.0020
482 URTICARIA 338 0.0020
483 THIRST 36 0.0020
484 SUICIDAL IDEATION 184 0.0020
485 HYPERLIPIDAEMIA 24 0.0020
486 WEIGHT FLUCTUATION 21 0.0020
487 MANIA 33 0.0020
488 ANKLE FRACTURE 31 0.0020
489 DYSPEPSIA 197 0.0020
490 UTERINE CANCER 16 0.0020
491 HYPERSOMNIA 57 0.0020
492 GASTROENTERITIS 29 0.0020
493 LACRIMATION INCREASED 60 0.0020
494 NASOPHARYNGITIS 366 0.0020
495 FRUSTRATION TOLERANCE DECREASED 16 0.0020
496 SWELLING 185 0.0020
497 SOMNOLENCE 398 0.0020
498 HIDRADENITIS 18 0.0020
499 INJECTION SITE IRRITATION 25 0.0020
500 ERUCTATION 38 0.0020
501 DIZZINESS 978 0.0020
502 URINARY INCONTINENCE 58 0.0020
503 FLATULENCE 111 0.0020
504 NAUSEA 1546 0.0020
505 ANGER 66 0.0019
506 RESPIRATORY TRACT CONGESTION 31 0.0019
507 MYDRIASIS 25 0.0019
508 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
509 SPINAL OPERATION 24 0.0019
510 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 33 0.0019
511 PRODUCT DISTRIBUTION ISSUE 18 0.0019
512 GENERALISED OEDEMA 24 0.0019
513 CONTUSION 186 0.0019
514 BLOOD CHOLESTEROL INCREASED 90 0.0019
515 ARTHRALGIA 801 0.0019
516 VENTRICULAR EXTRASYSTOLES 20 0.0019
517 APHASIA 58 0.0019
518 ABDOMINAL PAIN UPPER 395 0.0019
519 PARANOIA 33 0.0019
520 ABDOMINAL PAIN 445 0.0019
521 PROCEDURAL PAIN 53 0.0019
522 EYE SWELLING 71 0.0019
523 EAR PAIN 37 0.0019
524 HAEMORRHOIDS 37 0.0019
525 GASTROINTESTINAL INFECTION 17 0.0019
526 INFLUENZA LIKE ILLNESS 156 0.0019
527 PRODUCT PACKAGING ISSUE 18 0.0019
528 ECZEMA 99 0.0019
529 CHOLELITHIASIS 62 0.0019
530 FLUSHING 192 0.0019
531 RHINORRHOEA 122 0.0019
532 GINGIVAL PAIN 15 0.0019
533 BLOOD PRESSURE INCREASED 288 0.0019
534 WITHDRAWAL SYNDROME 79 0.0019
535 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90 0.0019
536 ORAL DISCOMFORT 26 0.0019
537 DRY THROAT 19 0.0019
538 HAIR TEXTURE ABNORMAL 25 0.0019
539 LYMPHADENOPATHY 66 0.0019
540 CATARACT 111 0.0019
541 TENDON RUPTURE 23 0.0019
542 UPPER LIMB FRACTURE 37 0.0019
543 DIZZINESS POSTURAL 18 0.0019
544 EUPHORIC MOOD 19 0.0019
545 PHARYNGITIS 23 0.0019
546 DECREASED ACTIVITY 20 0.0019
547 PRESYNCOPE 45 0.0018
548 PHARYNGITIS STREPTOCOCCAL 20 0.0018
549 PRODUCT AVAILABILITY ISSUE 42 0.0018
550 BACK INJURY 20 0.0018
551 CHOLECYSTECTOMY 21 0.0018
552 INCREASED APPETITE 35 0.0018
553 EATING DISORDER 39 0.0018
554 SNEEZING 41 0.0018
555 ANKYLOSING SPONDYLITIS 24 0.0018
556 OBESITY 29 0.0018
557 ADRENAL INSUFFICIENCY 22 0.0018
558 LIMB INJURY 49 0.0018
559 SALIVARY HYPERSECRETION 18 0.0018
560 OSTEOPOROSIS 74 0.0018
561 POLLAKIURIA 75 0.0018
562 ARTHRITIS 141 0.0018
563 PRURITUS 687 0.0018
564 HYPOAESTHESIA 266 0.0018
565 INJECTION SITE INDURATION 23 0.0018
566 ABDOMINAL DISCOMFORT 297 0.0018
567 INJECTION SITE DISCOLOURATION 22 0.0018
568 FACIAL PARALYSIS 15 0.0018
569 COGNITIVE DISORDER 82 0.0018
570 HYPOKALAEMIA 81 0.0018
571 THERAPEUTIC RESPONSE SHORTENED 58 0.0017
572 CARDIAC MURMUR 15 0.0017
573 MUSCULAR WEAKNESS 197 0.0017
574 MENTAL IMPAIRMENT 42 0.0017
575 INJECTION SITE REACTION 119 0.0017
576 BLOOD POTASSIUM DECREASED 52 0.0017
577 HEART RATE IRREGULAR 39 0.0017
578 PETECHIAE 18 0.0017
579 PERSONALITY CHANGE 16 0.0017
580 PRODUCT PRESCRIBING ERROR 41 0.0017
581 APHONIA 24 0.0017
582 CHEST DISCOMFORT 176 0.0017
583 URINARY TRACT INFECTION 293 0.0017
584 COMPLICATION OF DEVICE REMOVAL 31 0.0017
585 FEAR 46 0.0017
586 HYPONATRAEMIA 96 0.0017
587 SKIN REACTION 24 0.0017
588 HYPOTONIA 17 0.0017
589 PSORIATIC ARTHROPATHY 69 0.0017
590 RASH PAPULAR 38 0.0017
591 INJECTION SITE RASH 52 0.0017
592 LEUKOPENIA 84 0.0017
593 DYSPHONIA 98 0.0017
594 BEDRIDDEN 22 0.0017
595 HERPES ZOSTER 96 0.0017
596 DERMATITIS 35 0.0017
597 LOSS OF LIBIDO 15 0.0017
598 EYE PRURITUS 56 0.0017
599 OROPHARYNGEAL DISCOMFORT 15 0.0017
600 BIPOLAR DISORDER 18 0.0017
601 INJECTION SITE ERYTHEMA 205 0.0017
602 AMNESIA 107 0.0016
603 OCULAR HYPERAEMIA 78 0.0016
604 JOINT RANGE OF MOTION DECREASED 22 0.0016
605 NEPHROLITHIASIS 75 0.0016
606 LETHARGY 94 0.0016
607 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 331 0.0016
608 SCIATICA 26 0.0016
609 MUSCLE SPASTICITY 20 0.0016
610 LIP SWELLING 54 0.0016
611 NIGHTMARE 56 0.0016
612 INFLUENZA 180 0.0016
613 UNEVALUABLE EVENT 122 0.0016
614 PAIN IN EXTREMITY 474 0.0016
615 INCONTINENCE 17 0.0016
616 JOINT DISLOCATION 17 0.0016
617 BACTERIAL INFECTION 30 0.0016
618 ORTHOSTATIC HYPOTENSION 28 0.0016
619 PARALYSIS 23 0.0016
620 PRODUCT PRESCRIBING ISSUE 35 0.0016
621 TOOTHACHE 29 0.0016
622 MYALGIA 272 0.0016
623 DRUG EFFECT DECREASED 86 0.0016
624 BALANCE DISORDER 138 0.0016
625 INJECTION SITE MASS 59 0.0016
626 INFLAMMATION 82 0.0016
627 MEMORY IMPAIRMENT 218 0.0016
628 MUSCULOSKELETAL STIFFNESS 139 0.0016
629 SKIN FISSURES 31 0.0016
630 TREMOR 263 0.0016
631 COORDINATION ABNORMAL 22 0.0016
632 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
633 EYE INFLAMMATION 15 0.0016
634 TOOTH ABSCESS 16 0.0016
635 SLUGGISHNESS 16 0.0016
636 CELLULITIS 79 0.0016
637 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 282 0.0016
638 VIRAL INFECTION 52 0.0016
639 DRUG PRESCRIBING ERROR 30 0.0016
640 SENSORY DISTURBANCE 25 0.0016
641 RESTLESSNESS 57 0.0016
642 OESOPHAGITIS 17 0.0016
643 RASH PRURITIC 84 0.0015
644 CARDIOMEGALY 19 0.0015
645 GASTROINTESTINAL DISORDER 138 0.0015
646 DIPLOPIA 40 0.0015
647 INJECTION SITE DISCOMFORT 16 0.0015
648 ANOSMIA 22 0.0015
649 ECONOMIC PROBLEM 23 0.0015
650 RASH MACULAR 53 0.0015
651 CHEST PAIN 280 0.0015
652 POST PROCEDURAL COMPLICATION 29 0.0015
653 APATHY 22 0.0015
654 WEIGHT DECREASED 419 0.0015
655 BODY HEIGHT DECREASED 16 0.0015
656 HEPATIC CYTOLYSIS 19 0.0015
657 GAIT DISTURBANCE 285 0.0015
658 BONE PAIN 87 0.0015
659 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
660 DRUG INTERACTION 235 0.0015
661 PRODUCT DOSE OMISSION ISSUE 435 0.0015
662 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
663 COLD SWEAT 26 0.0015
664 COUGH 412 0.0015
665 DYSURIA 54 0.0015
666 EYELID OEDEMA 17 0.0015
667 DEEP VEIN THROMBOSIS 95 0.0015
668 WOUND INFECTION 16 0.0015
669 ASPIRATION 16 0.0015
670 INJECTION SITE WARMTH 30 0.0015
671 INJECTION SITE NODULE 16 0.0015
672 DYSPHAGIA 138 0.0015
673 SPEECH DISORDER 76 0.0014
674 INJECTION SITE SWELLING 111 0.0014
675 PAIN OF SKIN 39 0.0014
676 DENTAL CARIES 16 0.0014
677 TOOTH DISORDER 32 0.0014
678 SARS-COV-2 TEST POSITIVE 19 0.0014
679 CHOKING 28 0.0014
680 ADVERSE REACTION 19 0.0014
681 DERMATITIS ALLERGIC 18 0.0014
682 MALAISE 627 0.0014
683 CHOLECYSTITIS 17 0.0014
684 KNEE ARTHROPLASTY 30 0.0014
685 BLOOD TEST ABNORMAL 20 0.0014
686 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78 0.0014
687 DISABILITY 28 0.0014
688 HAEMORRHAGE 148 0.0014
689 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
690 BACK DISORDER 23 0.0014
691 LYMPHOCYTE COUNT DECREASED 25 0.0014
692 DRUG INEFFECTIVE 1861 0.0014
693 PULMONARY MASS 21 0.0014
694 SKIN DISORDER 47 0.0014
695 CONDITION AGGRAVATED 428 0.0014
696 DEVICE BREAKAGE 57 0.0014
697 MULTIPLE SCLEROSIS 67 0.0014
698 GENITAL HAEMORRHAGE 18 0.0014
699 MUSCULOSKELETAL DISCOMFORT 24 0.0014
700 OXYGEN SATURATION DECREASED 78 0.0014
701 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
702 FEEDING DISORDER 28 0.0014
703 INJECTION SITE PAIN 423 0.0014
704 INJECTION SITE BRUISING 110 0.0014
705 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
706 PAIN IN JAW 39 0.0014
707 HIP ARTHROPLASTY 21 0.0014
708 PULMONARY EMBOLISM 130 0.0014
709 HAIR COLOUR CHANGES 17 0.0014
710 SPINAL PAIN 16 0.0014
711 PRODUCT PREPARATION ERROR 28 0.0014
712 HEMIPARESIS 23 0.0014
713 MUSCULOSKELETAL PAIN 71 0.0014
714 CARDIOMYOPATHY 20 0.0014
715 SKIN HAEMORRHAGE 20 0.0013
716 CONJUNCTIVITIS 25 0.0013
717 BASAL CELL CARCINOMA 21 0.0013
718 COLITIS ULCERATIVE 60 0.0013
719 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
720 NEEDLE ISSUE 39 0.0013
721 DISORIENTATION 53 0.0013
722 DIARRHOEA 863 0.0013
723 DYSSTASIA 39 0.0013
724 TASTE DISORDER 27 0.0013
725 MOUTH ULCERATION 28 0.0013
726 HYPOAESTHESIA ORAL 20 0.0013
727 EXPIRED PRODUCT ADMINISTERED 44 0.0013
728 WRONG TECHNIQUE IN DRUG USAGE PROCESS 48 0.0013
729 COAGULOPATHY 22 0.0013
730 PRODUCTIVE COUGH 63 0.0013
731 ROAD TRAFFIC ACCIDENT 55 0.0013
732 RIB FRACTURE 27 0.0013
733 HAEMATOCRIT DECREASED 26 0.0013
734 IMPAIRED HEALING 43 0.0013
735 SEDATION 34 0.0013
736 HEAD INJURY 41 0.0013
737 PERIPHERAL SWELLING 199 0.0013
738 OEDEMA PERIPHERAL 157 0.0013
739 ANAPHYLACTIC REACTION 71 0.0013
740 EYE DISORDER 42 0.0013
741 MOVEMENT DISORDER 41 0.0013
742 BODY TEMPERATURE INCREASED 26 0.0013
743 LYMPHOPENIA 18 0.0013
744 NEUROPATHY PERIPHERAL 121 0.0013
745 MALIGNANT MELANOMA 17 0.0013
746 VOMITING 596 0.0013
747 JAUNDICE 34 0.0013
748 MUSCLE ATROPHY 16 0.0013
749 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
750 BRONCHOSPASM 18 0.0013
751 ARTHROPATHY 70 0.0013
752 DEVICE USE ISSUE 22 0.0013
753 OEDEMA 68 0.0013
754 DYSPNOEA 707 0.0012
755 SKIN DISCOLOURATION 57 0.0012
756 ASTHENIA 465 0.0012
757 PHARYNGEAL OEDEMA 19 0.0012
758 DYSKINESIA 50 0.0012
759 PLATELET COUNT INCREASED 16 0.0012
760 VISUAL IMPAIRMENT 152 0.0012
761 LOSS OF CONSCIOUSNESS 157 0.0012
762 DYSARTHRIA 46 0.0012
763 TACHYCARDIA 108 0.0012
764 DEVICE DEFECTIVE 21 0.0012
765 ABNORMAL BEHAVIOUR 48 0.0012
766 MOBILITY DECREASED 87 0.0012
767 MUSCULOSKELETAL DISORDER 23 0.0012
768 PULMONARY HYPERTENSION 25 0.0012
769 DEHYDRATION 160 0.0012
770 SINUS TACHYCARDIA 17 0.0012
771 EXPOSURE VIA SKIN CONTACT 31 0.0012
772 INTESTINAL OBSTRUCTION 45 0.0012
773 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
774 PSYCHOTIC DISORDER 35 0.0012
775 DRY SKIN 158 0.0012
776 STAPHYLOCOCCAL INFECTION 39 0.0012
777 ABASIA 29 0.0012
778 HYPOKINESIA 17 0.0012
779 LIVER FUNCTION TEST INCREASED 25 0.0012
780 AGEUSIA 29 0.0012
781 OSTEOMYELITIS 21 0.0012
782 BLOOD URINE PRESENT 22 0.0012
783 GASTRIC ULCER 22 0.0012
784 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
785 THERAPY PARTIAL RESPONDER 18 0.0012
786 PRESCRIBED UNDERDOSE 23 0.0012
787 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
788 PRODUCT DISPENSING ERROR 25 0.0011
789 ACNE 87 0.0011
790 MASS 16 0.0011
791 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
792 HAEMATOCHEZIA 63 0.0011
793 BLISTER 64 0.0011
794 IMMUNE SYSTEM DISORDER 15 0.0011
795 INJURY 80 0.0011
796 FALL 378 0.0011
797 INCORRECT DOSE ADMINISTERED 259 0.0011
798 FEMUR FRACTURE 35 0.0011
799 ABSCESS 18 0.0011
800 SEIZURE 130 0.0011
801 MULTIPLE SCLEROSIS RELAPSE 77 0.0011
802 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
803 MENSTRUATION IRREGULAR 30 0.0011
804 AGITATION 82 0.0011
805 SKIN EXFOLIATION 94 0.0011
806 DRUG DISPENSING ERROR 17 0.0011
807 UNDERDOSE 81 0.0011
808 PROTEINURIA 21 0.0011
809 AKATHISIA 15 0.0011
810 BONE DISORDER 20 0.0011
811 LOWER LIMB FRACTURE 21 0.0011
812 ACUTE RESPIRATORY FAILURE 21 0.0011
813 HALLUCINATION, VISUAL 23 0.0011
814 SKIN BURNING SENSATION 78 0.0011
815 THERAPEUTIC RESPONSE DECREASED 66 0.0011
816 ANGIOEDEMA 48 0.0011
817 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
818 HYPOACUSIS 46 0.0011
819 SKIN CANCER 23 0.0011
820 THERAPY NON-RESPONDER 48 0.0011
821 SYNCOPE 106 0.0011
822 DEVICE ISSUE 95 0.0011
823 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 75 0.0011
824 PLEURAL EFFUSION 64 0.0011
825 EPILEPSY 32 0.0010
826 MEDICATION ERROR 58 0.0010
827 PRODUCT DOSE OMISSION 68 0.0010
828 INTENTIONAL SELF-INJURY 21 0.0010
829 RESPIRATORY DISORDER 31 0.0010
830 HERNIA 20 0.0010
831 MENTAL DISORDER 45 0.0010
832 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
833 PANCREATITIS ACUTE 23 0.0010
834 GAIT INABILITY 34 0.0010
835 PRURITUS GENERALISED 22 0.0010
836 DRUG ADMINISTRATION ERROR 31 0.0010
837 BLOOD SODIUM DECREASED 19 0.0010
838 BLOOD PRESSURE ABNORMAL 20 0.0010
839 ULCER 16 0.0010
840 HAEMATOMA 26 0.0010
841 THROMBOSIS 80 0.0010
842 NO ADVERSE EVENT 179 0.0010
843 CHRONIC KIDNEY DISEASE 75 0.0010
844 HYPOPHAGIA 25 0.0010
845 DECREASED APPETITE 226 0.0010
846 ARRHYTHMIA 46 0.0010
847 PRODUCT STORAGE ERROR 85 0.0010
848 SKIN ULCER 25 0.0010
849 RASH GENERALISED 25 0.0010
850 TOOTH LOSS 20 0.0010
851 VISUAL ACUITY REDUCED 32 0.0010
852 SKIN IRRITATION 44 0.0010
853 INCORRECT DRUG ADMINISTRATION DURATION 27 0.0010
854 ANHEDONIA 25 0.0010
855 TREATMENT NONCOMPLIANCE 52 0.0009
856 LABORATORY TEST ABNORMAL 28 0.0009
857 FACE OEDEMA 16 0.0009
858 CONFUSIONAL STATE 153 0.0009
859 CIRCULATORY COLLAPSE 16 0.0009
860 BLOOD PRESSURE DECREASED 62 0.0009
861 HYPERGLYCAEMIA 34 0.0009
862 GASTRIC DISORDER 32 0.0009
863 INJECTION SITE HAEMORRHAGE 74 0.0009
864 BLOOD BILIRUBIN INCREASED 25 0.0009
865 PHARMACEUTICAL PRODUCT COMPLAINT 24 0.0009
866 ADVERSE DRUG REACTION 83 0.0009
867 LUNG DISORDER 45 0.0009
868 DRUG DOSE OMISSION 149 0.0009
869 SPINAL FRACTURE 18 0.0009
870 COLITIS 34 0.0009
871 PULMONARY FIBROSIS 17 0.0009
872 HYPOTENSION 177 0.0009
873 DEAFNESS 23 0.0009
874 C-REACTIVE PROTEIN INCREASED 32 0.0009
875 SKIN LESION 24 0.0009
876 CARDIAC FAILURE 70 0.0009
877 NEOPLASM PROGRESSION 30 0.0009
878 BONE DENSITY DECREASED 27 0.0009
879 ILL-DEFINED DISORDER 52 0.0009
880 DYSPNOEA EXERTIONAL 32 0.0008
881 ADVERSE EVENT 78 0.0008
882 INCORRECT DOSE ADMINISTERED BY DEVICE 22 0.0008
883 URINARY RETENTION 28 0.0008
884 RENAL DISORDER 39 0.0008
885 EMOTIONAL DISTRESS 101 0.0008
886 CHOLESTASIS 16 0.0008
887 NERVOUS SYSTEM DISORDER 26 0.0008
888 SEROTONIN SYNDROME 16 0.0008
889 GLAUCOMA 16 0.0008
890 FAECES DISCOLOURED 18 0.0008
891 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 28 0.0008
892 WHEEZING 49 0.0008
893 THERAPY INTERRUPTED 59 0.0008
894 WOUND 23 0.0008
895 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
896 RECTAL HAEMORRHAGE 35 0.0008
897 EXTRA DOSE ADMINISTERED 33 0.0008
898 INTENTIONAL DRUG MISUSE 17 0.0008
899 TRANSAMINASES INCREASED 18 0.0008
900 ASPARTATE AMINOTRANSFERASE INCREASED 43 0.0008
901 HALLUCINATION 61 0.0008
902 PALLOR 22 0.0008
903 HYPOGLYCAEMIA 39 0.0008
904 HYPOXIA 28 0.0008
905 LOCALISED INFECTION 19 0.0008
906 TYPE 2 DIABETES MELLITUS 26 0.0008
907 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
908 GLOSSODYNIA 17 0.0008
909 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
910 EPISTAXIS 56 0.0007
911 WHITE BLOOD CELL COUNT DECREASED 81 0.0007
912 STOMATITIS 45 0.0007
913 ATRIAL FIBRILLATION 72 0.0007
914 BLINDNESS 30 0.0007
915 PNEUMONIA 237 0.0007
916 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
917 AGGRESSION 36 0.0007
918 PANCREATITIS 38 0.0007
919 CONVULSION 41 0.0007
920 ANAEMIA 135 0.0007
921 HEPATITIS 18 0.0007
922 ENCEPHALOPATHY 17 0.0007
923 PERICARDIAL EFFUSION 16 0.0007
924 ACCIDENTAL EXPOSURE TO PRODUCT 71 0.0007
925 RESPIRATORY DISTRESS 19 0.0007
926 LIVER FUNCTION TEST ABNORMAL 20 0.0007
927 MENTAL STATUS CHANGES 19 0.0007
928 SUICIDE ATTEMPT 41 0.0007
929 ORAL PAIN 15 0.0007
930 DIABETES MELLITUS 51 0.0007
931 RED BLOOD CELL COUNT DECREASED 19 0.0007
932 PNEUMONITIS 18 0.0007
933 DRUG WITHDRAWAL SYNDROME 57 0.0006
934 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
935 HAEMOGLOBIN DECREASED 65 0.0006
936 DEVICE LEAKAGE 27 0.0006
937 BRADYCARDIA 33 0.0006
938 DEVICE DISLOCATION 27 0.0006
939 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
940 DELIRIUM 21 0.0006
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
942 METABOLIC ACIDOSIS 19 0.0006
943 CEREBROVASCULAR ACCIDENT 100 0.0006
944 RESPIRATORY FAILURE 43 0.0006
945 INCORRECT ROUTE OF DRUG ADMINISTRATION 21 0.0006
946 DEVICE DELIVERY SYSTEM ISSUE 16 0.0006
947 HAEMATURIA 20 0.0006
948 DEVICE MALFUNCTION 41 0.0006
949 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
950 SEPSIS 65 0.0006
951 DRUG EFFECT INCOMPLETE 21 0.0006
952 ANGINA PECTORIS 16 0.0006
953 BLOOD GLUCOSE DECREASED 26 0.0005
954 BLOOD CREATININE INCREASED 35 0.0005
955 CARDIAC DISORDER 50 0.0005
956 HEPATIC FAILURE 16 0.0005
957 LIVER DISORDER 23 0.0005
958 DEVICE DIFFICULT TO USE 34 0.0005
959 INTENTIONAL OVERDOSE 32 0.0005
960 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
961 SEPTIC SHOCK 21 0.0005
962 HOSPITALISATION 72 0.0005
963 HIP FRACTURE 15 0.0005
964 NEUTROPHIL COUNT DECREASED 19 0.0005
965 ACCIDENTAL OVERDOSE 17 0.0005
966 PLATELET COUNT DECREASED 48 0.0004
967 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
968 ACUTE KIDNEY INJURY 67 0.0004
969 DEVICE EXPULSION 28 0.0004
970 RENAL FAILURE 57 0.0004
971 BLOOD GLUCOSE INCREASED 80 0.0004
972 RENAL FAILURE ACUTE 18 0.0004
973 CEREBRAL HAEMORRHAGE 15 0.0004
974 FEBRILE NEUTROPENIA 27 0.0004
975 CARDIAC FAILURE CONGESTIVE 32 0.0004
976 PANCYTOPENIA 21 0.0004
977 DRUG DOSE OMISSION BY DEVICE 29 0.0004
978 MYOCARDIAL INFARCTION 62 0.0004
979 DISEASE PROGRESSION 41 0.0003
980 NEUTROPENIA 43 0.0003
981 TOXICITY TO VARIOUS AGENTS 48 0.0003
982 RENAL IMPAIRMENT 22 0.0003
983 NEOPLASM MALIGNANT 17 0.0003
984 DRUG ABUSE 17 0.0002
985 CARDIAC ARREST 16 0.0002
986 COMPLETED SUICIDE 16 0.0002
987 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
989 DEATH 103 0.0001
990 DRUG DEPENDENCE 18 0.0001